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Abstract 
Although now believed to be two distinct disorders, autism spectrum disorders (ASD) and 
schizophrenia spectrum disorders (SSD) share multiple phenotypic similarities and risk factors, and 
have been reported to co-occur at elevated rates. In this narrative review, we give a brief overview of 
the phenomenological, genetic, environmental, and imaging evidence for the overlap between ASD 
and SSD, highlighting similarities and areas of distinction. We examine eight possible alternate 
models of explanation for the association and comorbidity between the disorders, and set out a 
research agenda to test these models. Understanding how and why these disorders co-occur has 
important implications for diagnosis, treatment, and prognosis, as well as for developing fundamental 
aetiological models of the disorders. 
 
Keywords 
Autism, psychosis, schizophrenia, Aspergers’s, comorbidity, model, diagnosis 
 
 
 
 
 
 
 
 
3 
 
Main text 
1. Introduction 
SSD and ASD are currently conceptualised as separate illnesses. Schizophrenia spectrum disorders 
(SSD), as defined by the DSM-5, include schizophrenia, other psychotic disorders, and schizotypal 
personality disorder. They involve delusions, hallucinations, disorganized thinking, disorganized 
behaviour, and negative symptoms. Autism-spectrum disorders (ASD), included by the DSM-5 under 
neurodevelopmental disorders, are diagnosed when deficits of social communication and interaction 
are accompanied by markedly repetitive patterns of behaviour, interests, or activities. ASD traits are 
present in the early developmental period and may be with or without an accompanying intellectual or 
language impairment. This however, has not always been the case. Definitions of ASD and SSD have 
undergone many revisions (with much of the research cited in this review using DSM-IV or earlier 
definitions).  Bleuler (1950) believed that autism was a central feature of schizophrenia, while others 
viewed it as the childhood onset of the disorder (Bender, 1947). In fact, the term autism was used 
interchangeably with schizophrenia until the 1970s, when Rutter (1972) and Kolvin (1971) proposed 
that they were distinct disorders. The nosologic separation between ASD and SSD may initially 
appear justified. SSD has a typical adolescent onset with prominent positive psychotic symptoms, 
while ASD is characterised by deficits in social interaction, communication and behaviour that begin 
within the first few years of life (American Psychiatric Association, 1994). Despite apparent 
differences, SSD and ASD share multiple phenotypic similarities and risk factors (Hamlyn, Duhig, 
McGrath, & Scott, 2013; Spek & Wouters, 2010), have both been conceptualised as 
neurodevelopmental rather than neurodegenerative disorders (Goldstein, Minshew, Allen, & Seaton, 
2002), and have been reported to co-occur at elevated rates (Mouridsen, Rich, & Isager, 2008; 
Rapoport, Chavez, Greenstein, Addington, & Gogtay, 2009; Solomon et al., 2011; Stahlberg, 
Soderstrom, Rastam, & Gillberg, 2004). Systematic research on their co-occurrence has been limited, 
although emerging genetic and neuroanatomical evidence has led to increasing recognition of the 
overlap between the conditions (Carroll & Owen, 2009; Cheung et al., 2010).  
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In this paper we briefly review the phenomenological, genetic, environmental, and imaging evidence 
for the overlap between ASD and SSD, in order to highlight similarities and areas of distinction 
between the disorders. We then examine alternative models of explanation for the association between 
the disorders, and set out a research agenda to test these models. Understanding how and why these 
disorders co-occur has important implications for diagnosis, treatment, and prognosis, as well as for 
developing a fundamental understanding of the aetiologies of these disorders. 
2. Phenomenology, diagnoses and overlapping traits 
2.1 Co-occurrence at the diagnostic level  
Although there have been reports that SSD and ASD do not co-occur at elevated rates (Volkmar & 
Cohen, 1991), the majority of research suggests that the disorders co-occur at a higher rate than would 
be expected in the general population. A brief literature search (database: Web of Science, search 
terms: Autism AND psychosis AND diagnosis, conducted March 2015) reveals 14 papers published 
in the past 10 years, which investigate diagnostic rates of ASD in individuals with SSD, or vice versa. 
Of these, 9 investigate rates of SSD in ASD populations, and five rates of ASD in those diagnosed 
with SSD.  
In populations with ASD, rates of comorbid SSD have been variably reported from 0% - 34.8%. A 
similar pattern emerges when considering ASD in SSD populations where reported rates vary from 
3.6% - 60% (see table 1). Childhood-onset schizophrenia (COS) in particular has been linked to ASD, 
with estimates that 30-50% of cases are preceded by a diagnosis of a Pervasive Developmental 
Disorder (Rapoport et al., 2009). A systematic review by Padgett et al. (2010) found that in 
individuals with SSD, rates of pervasive developmental disorders, including ASD, were estimated at 
18-56%, but noted that all of the studies highlighted by their search reported research conducted with 
populations less than 18 years old, despite their search not being intentionally limited to this age 
range. In adult SSD populations less is known about the prevalence of ASD.  
 
5 
 
Table 1: Rates of co-occurrence between ASD and SSD 
Authors n % co-
occurrence 
SSD in ASD populations 
Eaves and Ho (2008) 48 young adults with ASD 0% 
Lugnegard, Hallerback, and Gillberg 
(2011) 
54 young adults with Asperger syndrome 3.7% 
Mouridsen, Rich, and Isager (2008) 118 individuals diagnosed as children 
with infantile autism 
6.6% 
Billstedt, Gillberg, and Gillberg 
(2005) 
120 individuals with autism diagnosed in 
childhood 
7% 
Hofvander et al. (2009) 122 adults with normal intelligence 
ASDs 
12% 
Stahlberg et al. (2004) 129 adults diagnosed with ASD 14.8% 
Joshi et al. (2010) 217 children and adolescents meeting 
diagnostic criteria for an ASD 
20% 
Bakken et al. (2010) 62 adults with autism and intellectual 
disability 
25.1% 
Mouridsen et al. (2008) 89 individuals with atypical autism 34.8% 
ASD in SSD populations 
Davidson, Greenwood, Stansfield, and 
Wright (2014) 
197 adults attending an early 
intervention in psychosis service  
3.6% 
Sporn et al. (2004) 75 children with COS 3.9%  
Solomon et al. (2011) 16 individuals with first episode of 
psychosis 
19% 
Waris, Lindberg, Kettunen, and Tani 
(2013) 
18 adolescents with early onset 
schizophrenia 
44% 
Hallerback, Lugnegard, and Gillberg 
(2012) 
46 adults with a diagnoses of 
schizophrenic psychotic disorders 
50-60% 
 
As ASD and SSD both occur in around 1% of the population (Brugha et al., 2011; Kendler, Gallagher, 
Abelson, & Kessler, 1996; Centers for Disease Control and Prevention, 2012; van Os, Hanssen, Bijl, 
& Vollebergh, 2001), studies with fewer than 100 participants are unlikely to be truly representative. 
Of the 14 papers mentioned 6 had samples of over 100 participants (Billstedt et al., 2005; Davidson et 
al., 2014; Hofvander et al., 2009; Joshi et al., 2010; Mouridsen et al., 2008; Stahlberg et al., 2004). 
These papers found a mean incidence of 12.8% of SSD in ASD populations, with only one study 
reporting on ASD in SSD with a sample of over 100 (Davidson et al., 2014) and finding an incidence 
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rate of 3.6%. Large population studies are needed to ascertain true diagnostic comorbidities in ASD 
and SSD.  
2.2 Co-occurrence at the trait level 
SSD and ASD are both hypothesised to exist on extended phenotypic continua (Folstein & Rutter, 
1977; van Os, Hanssen, Bijl, & Ravelli, 2000), and it is therefore important to consider not only co-
occurrence at the diagnostic level, but also to investigate evidence of overlap in traits. A descriptive 
overlap exists in the traits that make up the diagnostic criteria for ASD and SSD. Both disorders 
include deficits in social interaction and communication as primary symptoms; the lack of emotional 
reciprocity in ASD can be compared to blunted affect (a lack of emotional response) in SSD; the 
delay or lack of speech development in ASD parallels alogia (poverty of speech) in SSD; and 
catatonic features are observed in both diagnoses. It is perhaps unsurprising that much research has 
found co-occurrence of traits such as these (e.g. Brüne, 2005; Spek & Wouters, 2010). Similarities are 
also found in traits that relate to, but are not part of the diagnostic criteria. Theory of mind and 
mentalizing impairments are hypothesised to be central to both disorders (Baron-Cohen, Leslie, & 
Frith, 1985; Bora, Yucel, & Pantelis, 2009; Brüne, 2005; Chung, Barch, & Strube, 2013). Similarly, 
Eack et al. (2013) report that those with ASD and SSD experience similar deficits in their 
neurocognitive and social-cognitive functioning. 
What is more striking is that traits which, according to diagnostic criteria, should be found in only one 
of the disorders are often found in the other as well. For example, positive psychotic experiences are 
not mentioned in diagnostic criteria for ASD. Yet there is some evidence that these experiences may 
occur at elevated rates in ASD populations (Barneveld et al., 2011; Bevan Jones, Thapar, Lewis, & 
Zammit, 2012). Indeed, Konstantareas and Hewitt (2001) reported that 35% of their ASD sample 
displayed one or more positive symptom. Similarly, core ASD features such as circumscribed 
interests, resistance to change, and abnormal response to stimuli are not part of the diagnostic criteria 
for SSD but are often found in SSD populations (Esterberg, Trotman, Brasfield, Compton, & Walker, 
2008).  
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Conversely, other authors report traits which do differentiate between the disorders. Intellectual 
disability, for example, is more common in ASD than SSD (Baio, 2010; Cooper, 1997; Morgan, 
Leonard, Bourke, & Jablensky, 2008). Similarly, although both disorders show a higher male to 
female ratio in individuals diagnosed, the male-female ratio appears to be considerably higher in ASD 
than SSD (Ochoa, Usall, Cobo, Labad, & Kulkarni, 2012; Wing, 1981b). Level of communication 
deficits may also differentiate between ASD and SSD. In a study comparing individuals at risk for 
psychosis, those with a first episode of psychosis, individuals with autism and healthy controls, 
Solomon and colleagues (2011) found that although 20% of those in the high risk or first episode 
psychosis groups met diagnostic criteria for ASD as assessed by parental report, there were a number 
of traits which distinguished between the different diagnostic categories. Atypical developmental 
trajectories in communication and social behaviours, as well as structural and pragmatic language, 
were found in the ASD group to a much greater extent than the SSD and control groups. Similarly, 
when comparing individuals with ASD and SSD, Spek and Wouters (2010) demonstrated that 
individuals with ASD reported more impairment with social skills, attention switching, and 
communication than those with SSD.  
There is also longitudinal evidence for an overlap between ASD and SSD at the trait level. Evidence 
from two large cohort studies has confirmed that the presence of psychotic experiences at age 12 is 
associated with ASD traits earlier in life (Bevan Jones et al., 2012; Sullivan, Rai, Golding, Zammit, & 
Steer, 2013). Likewise, children who have received a diagnosis of ASD are more likely to report 
experiencing symptoms of psychosis during adolescence and adulthood (Joshi et al., 2013; Sullivan et 
al., 2013). Childhood deficits documented in those who later develop SSD mimic ASD traits; there is 
substantial evidence of early deficits in motor development (e.g. Fish, Marcus, Hans, Auerbach, & 
Perdue, 1992), cognition (e.g. Cannon et al., 2002), socialisation (e.g. Cannon et al., 2002; Jones, 
Rodgers, Murray, & Marmot, 1994) and communication (e.g. Bearden et al., 2000), many years 
before the expression of frank positive psychotic symptoms. These have recently been confirmed 
meta-analytically (Dickson, Laurens, Cullen, & Hodgins, 2011). Whether these traits reflect aspects of 
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ASD which were undiagnosed or did not reach clinical significance, or instead reflect the status of 
SSD as a neurodevelopmental disorder remains to be determined.  
Other research suggests, however, that ASD traits may not be predictive of the development of SSD. 
Esterberg et al. (2008) found that within their sample of adolescents with schizotypal personality 
disorder (SPD), adolescents with other personality disorders, and those with no personality disorder, 
childhood and current ASD features were predictive of schizotypal and ‘prodromal’ symptoms, but 
were not found to be predictive of the development of psychotic illness (although it needs to be noted 
that Esterberg et al.’s follow up was for just 3 years which may not be long enough for a conclusive 
evaluation of transition to frank psychosis). Research in the 22q11.2 deletion syndrome population 
has also suggested that ASD traits are not predictive of the development of SSD. A study from 
Vorstman and colleagues (2013) investigated childhood ASD traits in 78 patients with 22q11.2 
deletion syndrome, 36 of who had developed psychotic disorder. High levels of ASD traits were 
reported to have occurred during childhood in their population, but were not predictive of the 
development of SSD. Higher rates of ASD traits had a stronger association with the non-psychotic 
individuals with the deletion, suggesting that, in the case of 22q11.2 deletion syndrome, the disorders 
share a genetic vulnerability but are distinct in their expression of this vulnerability. 
2.3 Section summary 
ASD and SSD appear to co-occur diagnostically at a higher frequency than would be expected by 
chance. A trait overlap between the disorders exists both cross-sectionally and longitudinally. Overlap 
at the trait level, rather than diagnostically, is an important consideration, not only from an 
aetiological perspective, but also from a clinical one. For example, sub-threshold ASD traits may be 
important for tailoring psychosocial intervention for individuals with SSD.   
3. Overlapping risk factors 
3.1 Genetic evidence 
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Genetic evidence also highlights points of similarity and distinction between the disorders. The 
phenotypic similarities between SSD and ASD are mirrored by many overlapping genetic 
mechanisms. ASD and SSD rates of heritability are both estimated to be high at around 50-80%, 
(Cardno & Gottesman, 2000; Freitag, 2006; Sandin et al., 2014). What is particularly interesting is the 
fact that as well as showing high levels of heritability within each disorder, there is evidence of 
relatively high levels of heritability between the disorders. There is an increased risk for ASD in the 
offspring of parents with SSD (Larsson et al., 2005; Sullivan et al., 2012), higher levels of ASD traits 
among the siblings of children with COS (Sporn et al., 2004), and an increased rate of SSD in the 
parents of children with ASD than in parents of controls (Daniels et al., 2008).  
This is consistent with studies investigating copy number variants (CNVs; variations of DNA 
sequence in the genome) in SSD and ASD. Particular CNVs are implicated in both ASD and SSD, 
and specific rare alleles have been found to occur in both disorders (e.g. Lionel et al., 2013; McCarthy 
et al., 2009; Moreno-De-Luca et al., 2010; Vorstman et al., 2013; Weiss et al., 2008). The high 
number of shared CNV deletions and duplications, including NRXN1, CNTNAP2, 22q11.2, 1q21.1 
and 15q13.3, led Carroll and Owens (2009) to conclude in their review that genetic evidence 
challenges the assumption that ASD and SSD are completely unrelated disorders. The nature of this 
association is a matter of controversy, however, particularly in light of evidence suggesting that both 
disorders are diametrically related (Crespi, Stead, & Elliot, 2010). Crespi and colleagues propose this 
based on evidence that genetic risk factors in both disorders behave in a pleiotropic manner such that 
deletion of a part of the chromosome predisposes the individual to developing one disorder and 
duplication predisposes the other disorder. They also cite evidence showing that specific risk variants 
lead to up-regulation of growth-signalling pathways in ASD and down regulation of growth-signalling 
pathways in SSD.  
A particularly compelling example of overlapping genetic vulnerability comes from the high rates of 
ASD and SSD seen in individuals with 22q11.2 deletion syndrome. In the largest study to date, 
investigators examined psychiatric morbidity in 1402 individuals with the syndrome (Schneider et al., 
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2014). SSDs were found in 1.97% of children aged 6-12, 10.12% of adolescents age 13-17, 23.53% of 
emerging adults aged 18-25, 41.33% of young adults age 26-35, and 41.73% of mature adults aged 36 
or above. Similarly high rates of ASD were also found, with rates varying across the life span of 
12.77% for children, to 26.54% for adolescents, to 16.10% for adults.   
There is also evidence of genetic differentiation between the disorders. Whilst CNVs appear to be 
enriched in individuals with ASD and SSD, common risk alleles have not generally been found to be 
shared between the disorders. Using genome-wide genotype data from the Cross-Disorder Group of 
the Psychiatric Genomics Consortium (2013), only a low genetic correlation was found between ASD 
and SSD. This compares to strong to moderate correlations between schizophrenia and bipolar 
disorder, schizophrenia and major depressive disorder, bipolar disorder and major depressive disorder, 
and attention-deficit/hyperactivity disorder and major depressive disorder. Similarly, using a 
schizophrenia-derived polygenic score which covered common risk alleles, Vorstman et al. (2013) 
found no evidence for shared common genetic risk variants between ASD and SSD. The authors 
hypothesise that this suggests that common risk variants may play a limited role in ASD when 
compared to SSD, particularly when considering the lack of confirmed genome-wide association 
study results in ASD (Devlin, Melhem, & Roeder, 2011).  
3.2 Environmental factors 
As well as sharing genetic risk factors, SSD and ASD also share a remarkable number of 
environmental risk factors (Hamlyn et al., 2013). Many of these relate to obstetric complications 
(Atladottir et al., 2010; Brown et al., 2004; Cannon, Jones, & Murray, 2002; Gardener, Spiegelman, & 
Buka, 2009; Larsson et al., 2005). Cannon et al.’s (2002) meta-analysis found that antepartum 
haemorrhage, gestational diabetes, rhesus incompatibility, preeclampsia, low birth weight, congenital 
malformations, reduced head circumference, uterine atony, asphyxia, and emergency caesarean 
section were all associated with increased risk of developing schizophrenia. Similar results have been 
confirmed meta-analytically for ASD, with gestational diabetes, maternal bleeding during pregnancy, 
maternal medication use during pregnancy and psychiatric medication use during pregnancy all 
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highlighted as increasing risk of ASD (Gardener et al., 2009). Paternal age has also been identified as 
a potential risk factor both ASD and SSD, (particularly paternal age of >50; Gardener et al., 2009; 
McGrath et al., 2014; Miller et al., 2011). Again these results have been confirmed meta-analytically 
for both disorders, with Miller et al. ( 2011) reporting increased risk of SSD in offspring of fathers 
over 29 years of age, and Hultman, Sandin, Levine, Lichtenstein, and Reichenberg (2011) observing 
increased risk of ASD in offspring of fathers aged 30 or more. In both analyses, the highest risk was 
for offspring of fathers aged 50 or more. 
Other potential shared environmental risk factors have been more tentatively suggested. Urbanicity 
has been relatively robustly linked to the development of SSD (Marcelis, Navarro-Mateu, Murray, 
Selten, & van Os, 1998; Mortensen et al., 1999). Although an association between urbanicity during 
pregnancy and infanthood and the development of ASD has been observed (Lauritsen et al., 2014; 
Lauritsen, Pedersen, & Mortensen, 2005; Li, Sjöstedt, Sundquist, Zöller, & Sundquist, 2014), at least 
some of this observation may be explained by variations in access to diagnostic and medical services. 
Lauritsen et al. (2014) for example, utilising a Danish register-based cohort of more than 800,000 
children, found an increased risk of ASD in children who moved to higher levels of urbanicity in early 
childhood, as well as an earlier age of diagnosis in urban areas. These findings indirectly suggest that 
availability of diagnostic services may be at least partially responsible for the increased incidence of 
ASD observed in urban areas. The nutrition of the mother during pregnancy, in particular low prenatal 
vitamin D, has also been tentatively identified as a risk factor in both ASD (Cannell, 2008; Grant & 
Soles, 2009; Kočovská, Fernell, Billstedt, Minnis, & Gillberg, 2012) and SSD (McGrath, Burne, 
Féron, Mackay-Sim, & Eyles, 2010; McGrath et al., 2010). 
As with underlying genetic risk factors, there are also environmental risks which appear to be specific 
to one disorder or the other. For example, risk for SSD appears to be increased in first and second 
generation migrants (Cantor-Graae & Selten, 2005), whereas migrant status appears to be a risk for 
ASD specifically with regards to parental migration (Dealberto, 2011; Gardener et al., 2009; 
Magnusson et al., 2012). Similarly, prenatal famine has been linked to a two-fold increase in SSD but 
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has not currently been linked to ASD (Hoek et al., 1996; Roseboom, Painter, van Abeelen, 
Veenendaal, & de Rooij, 2011).   
3.3 Section summary 
Similar underlying risks exist between ASD and SSD, in terms of heritability and genetics, and in 
terms of environmental risk. On the other hand, there also appear to be areas of differentiation, with 
certain risk factors unique to one disorder but not the other. 
4. Brain structure and functioning 
Neuroimaging evidence presents a similar picture to phenomenological, genetic, and environmental 
risk factor research, with many similarities apparent between the disorders, but also some differences. 
In terms of similarities, both individuals with ASD and those with SSD have been found via meta-
analysis to show reduced grey matter volume in limbic-striato-thalamic circuitry, predominantly on 
the right, including the insula, posterior cingulate and parahippocampal gyrus (Cheung et al., 2010). 
In their review comparing individuals with ASD to those with COS, Baribeau and Anagnostou (2013) 
suggest there may be similarities in exaggerated volume loss during adolescence. They also note 
similarities in volume loss in prefrontal areas including the middle frontal gyrus, volume loss in the 
temporal-parietal junction, and volume gains in the caudate.  
Reduced fractional anisotropy values (reflecting altered white matter integrity) have also been found 
in both disorders (Mueller, Keeser, Reiser, Teipel, & Meindl, 2012). In ASD, implicated areas include 
the corpus callosum, the right corticospinal tract, the internal capsule, the left and right pedunculi 
cerebri, and the cingulate gyrus (Bloemen et al., 2010; Brito et al., 2009). Within SSD, implicated 
areas are the left frontal deep white matter including the frontal lobe, thalamus, and cingulate gyrus, 
and the left temporal deep white matter including the frontal lobe, insula, hippocampus-amygdala 
complex, and temporal and occipital lobes (Ellison-Wright & Bullmore, 2009). Comparisons between 
COS and ASD reveal that both disorders show volume loss in the corpus callosum and cingulum, as 
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well as reduced white matter integrity in the superior longitudinal fasciculus (Baribeau & 
Anagnostou, 2013). 
Functional imaging analyses have focused on social cognition as a primary feature of both disorders. 
A meta-analysis has shown that brain regions thought to be part of a social cognition network show 
hypoactivation in both ASD and SSD in response to social stimuli, most consistently seen in the 
medial prefrontal cortex and superior temporal sulcus (Sugranyes, Kyriakopoulos, Corrigall, Taylor, 
& Frangou, 2011). Similarly, a review from Abdi and Sharma (2004) found reductions in blood flow 
to the fusiform gyrus and abnormal amygdala activation during emotional perception tasks in both 
ASD and SSD.  
Neurochemical abnormalities such as dopamine disruption have also been observed in both disorders 
(Hérault et al., 1993; Muck-Seler et al., 2004; Stone, Morrison, & Pilowsky, 2007; Cartier, 2015). 
Within SSD dopamine disruption has been identified as a central feature of the disorder (Howes & 
Kapur, 2009; Winton-Brown, Fusar-Poli, Ungless, & Howes, 2014). Research into the dopamine 
system in ASD is more limited. In a study which compared 8 adults with Asperger syndrome to 5 
healthy controls using positron emission tomography (PET), Nieminen-von Wendt et al. (2004) found 
increased FDOPA influx (Ki) values in the striatum of the ASD group. Similarly, in another PET 
study which compared 20 individuals with ASD with control participants, an over-functioning of 
dopaminergic systems in the orbitofrontal cortex was suggested by a higher level of dopamine 
transporter bindings in the ASD group when compared to controls (Nakamura et al., 2010).  
There are also potential areas of distinction between the disorders. These include increased cerebral 
ventricles volume and a reduction in overall brain volume found in individuals with SSD but not ASD 
(Shenton, Dickey, Frumin, & McCarley, 2001; Toal et al., 2009), as well as decreased white matter 
integrity, again found in individuals diagnosed with SSD but not ASD (Davis et al., 2003; Hao et al., 
2006; Toal et al., 2009). In the only structural MRI study to date (to the authors knowledge) to 
directly compare ASD and SSD, Radeloff et al. (Radeloff et al., 2014) found no global grey matter or 
white matter differences between individuals with ASD, SSD, or controls. Participants with ASD 
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however, were found to have smaller grey matter volume in the left anterior insular when compared to 
those with SSD. In contrast to this, a positive correlation was observed between insular grey matter 
volume and hallucinatory behaviour in the SSD group. A meta-analysis from Cheung et al. (2010), 
which aimed to quantify structural similarities between ASD and SSD, found that abnormalities in the 
right and left superior and medial frontal gyrus, right and left cingulate, left insula, caudate, temporal 
gyrus and amygdala were specific to SSD, and abnormalities in the left putamen appeared specific to 
ASD. In their review comparing COS with ASD, Baribeau and Anagnostou (2013) report opposing 
patterns between the two conditions, with cortical surface area and volume showing patterns of 
overgrowth in early ASD but reduced thickness in individuals with COS. Similarly, they report a 
pattern of diametric results demonstrated in fMRI studies, with those diagnosed with COS showing 
increased long range connectivity with reduced short-range connectivity, compared to research 
suggesting that those diagnosed with ASD may display the reverse pattern (e.g. Courchesne & Pierce, 
2005; Just, Keller, Malave, Kana, & Varma, 2012). 
Other research, particularly studies investigating social deficits, has found opposing patterns of 
activation during fMRI. A recent study from Ciaramidaro et al. (2014), which directly compared 
individuals with ASD and SSD on different types of intentionality, found that activation between the 
right posterior superior temporal sulcus and the ventral medial prefrontal cortex was abnormal in both 
groups, with an increased connectivity found in those with SSD and a decreased connectivity in those 
with ASD. The increased connectivity in SSD was found during the control condition (‘physical 
intentionality’, e.g. a balloon is blown by a gust of wind), and the decreased connectivity in ASD was 
found during the experimental intention condition. The authors argue that this is consistent with the 
hypo-hyper-intentionality hypothesis (Abu-Akel & Bailey, 2000; Crespi & Badcock, 2008) that 
individuals with SSD over-attribute intentions to others and physical events, whereas those with ASD 
often fail to attribute intentions to others. This hypothesis parallels evidence from EEG studies which 
find reduced Mu suppression (used as marker for mirror neuron activity) in ASD participants  taking 
part in socio-emotional tasks (Oberman et al., 2005) and increased Mu suppression in those with SSD 
(McCormick et al., 2012).  
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A particularly interesting investigation of brain anatomy in individuals who had ASD compared to 
those with comorbid ASD and SSD found that the primary differences in those with comorbid ASD 
and SSD (compared to those with ASD alone) related to reductions in grey matter in the right insular 
cortex, the cerebellum, the fusiform gyrus and the lingual gyri (Toal et al., 2009). Toal et al. (2009) 
note that their participants with comorbid ASD and SSD did not display the same changes usually 
found in populations who have developed SSD such as an increased volume of cerebral ventricles 
with a reduction in total brain volume (Shenton et al., 2001). They suggest that their comorbid 
population appear to share more anatomical similarities with individuals in Ultra High Risk for 
psychosis (UHR) groups, rather than those with frank SSD, and point out that the cerebellum and 
fusiform gyrus (which showed reductions in their comorbid population) have been implicated in UHR 
individuals (alongside left parahippocampal gyrus, and the orbitofrontal and cingulate cortex; e.g. Job, 
Whalley, Johnstone, & Lawrie, 2005; Pantelis et al., 2003). Toal et al. suggest that these anatomical 
differences may hint that for some individuals, ASD represents a different pathway into SSD.  
5. Models of association 
Levels of co-occurrence and association within psychiatric disorders have long been considered 
contentious (Krueger & Markon, 2006). A differentiation can be made between the co-occurrence of 
two unrelated disorders, anorexia and hearing impairment for example, and disorders which correlate 
or co-occur above the level of chance, such as depression and anxiety disorders, or morbid obesity 
and heart failure. Many explanations of co-occurrence or association between disorders/diseases have 
been proposed (Crespi & Badcock, 2008; Kraemer, 1995; Krueger & Markon, 2006). These can be 
summarised as follows: 
1. The ‘multiformity’ model 
2. The ‘increased vulnerability’ model 
3. The ‘chance’ or ‘spurious association’ model 
4. The ‘stages’ model  
5. The ‘associated liabilities’ model 
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6. The ‘independence’ model 
7. The ‘diametrical’ model 
8. The ‘multiple overlapping aetiologies’ model 
 
Below we provide a brief description of these models followed by an evaluation of their fit in 
explaining the nature of the co-occurrence between ASD and SSD in lieu of current evidence.  
5.1 The multiformity model  
The multiformity model was one of four models (alongside the associated liabilities model, increased 
vulnerability model, and the independence model) proposed by Krueger and Markon (2006) as a 
potential bivariate model for understanding associations between two psychopathologies. The model 
suggests that two disorders which appear to co-occur may represent different manifestations of the 
same underlying disorder, with the underlying liability expressing itself in a number of ways. 
In the case of SSD and ASD the multiformity model would predict that although ASD and SSD have 
different expressions, they are in fact caused by the same underlying disorder. Interestingly, the 
multiformity model therefore entails that what are currently conceptualised as two separate disorders 
are in fact one, potentially leading round full circle to Bleuler’s original conception of the disorders.  
5.2 The increased vulnerability model 
The increased vulnerability model (termed the causation model by Krueger & Markon, 2006) 
theorises that one disorder may predispose another disorder, for example, in the way that obesity 
predisposes heart disease. Applied to ASD and SSD, the increased vulnerability model hypothesises 
that individuals who experience ASD will show an increased vulnerability developing a SSD, but that 
the disorders remain separate, with areas of distinction able to be made between them. 
5.3 The chance model 
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The chance model, discussed by Kraemer (1995), and termed the spurious association model by 
Krueger and Markon (2006), refers to disorders co-occurring due to chance, or due to external 
variables (such as misdiagnosis) which could lead to the appearance of co-occurrence. Other authors 
(e.g. Bishop, 2010) discuss ‘phenomimicry’, where the causal pathway for one disorder may lead to 
traits which mimic or resemble the other disorder. This similarity would be superficial, and not 
reflective of a deeper association between the disorders, but might nonetheless lead to higher levels of 
misdiagnosed comorbidity. 
5.4 The stages model 
The stages model postulates that two disorders which appear to co-occur are different stages of the 
same disorder. For example, the first stage of syphilis involves small, painless sores which disappear a 
few weeks before the disease progresses into its later stages which include more serious symptoms. 
When applied to ASD and SSD, the stages model suggests that ASD (whether at the diagnostic or trait 
level) may develop into SSD at a later stage. As with the multiformity model, if correct, the stages 
model also suggests that ASD and SSD are in fact one disorder rather than two.  
5.5 The associated liabilities model 
The associated liabilities model suggests that two disorders are related by shared risk factors, but are 
ultimately distinct. In the case of ASD and SSD it predicts that the disorders are separate but will 
share underlying genetic or environmental risks. 
5.6 The independence model 
The independence model proposes that when two disorders co-occur, the ‘comorbid disorders’ 
constitute a third independent disorder, which is distinct from the two disorders it is thought to be 
formed from. For example, rather than conceptualise people who experience periods of depression 
and periods of mania as experiencing two separate disorders, they are considered to experience a third 
disorder which encapsulates both of these: bipolar disorder. In the case of ASD and SSD, the 
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independence model would hypothesise that individuals who experience both an ASD and a SSD are 
actually experiencing a third, unique disorder.  
5.7 The diametrical model 
The diametrical model refers to disorders that emanate from reciprocal alterations to a common risk 
factor or factors. These disorders such as Beckwith-Wiedemann syndrome (involving overgrowth) 
versus Silver-Russell syndrome (involving undergrowth) or Prader-Willi versus Angelman syndromes 
present opposing profiles that result from either the deletion or duplications of a suite of common 
imprinted genes (see review by Crespi & Badcock, 2008). Having both ASD and SSD thus may be a 
consequence of carrying shared risk factors such as pleiotropic CNVs that confer risk for both 
disorders. When the disorders do co-occur, the diametrical model predicts that behaviour would be 
diametrically modulated towards normality by co-occurring phenotypic traits that are disorder-
specific.  
5.8 The multiple overlapping aetiologies model 
The multiple overlapping aetiologies model applies to disorders which show a high level of clinical 
heterogeneity and which have multiple aetiological pathways. When disorders like this co-occur, the 
multiple overlapping aetiologies model suggests that this is because the disorders may share some 
aetiological pathways, whilst other causal pathways remain specific to one disorder or the other. The 
multiple overlapping aetiologies model applied to ASD and SSD would suggest that ASD and SSD 
both consist of multiple clinical syndromes, and that some of these clinical syndromes share 
aetiological pathways. 
6. Evaluation of the co-occurrence and comorbidity of disorders 
Of the eight models presented there is only limited evidence for the chance, stages, independence, and 
multiformity models. The evidence for the association between ASD and SSD is relatively robust and 
multifaceted, suggests strongly that the disorders co-occur at elevated rates, and thus precludes the 
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possibility that the disorders co-occur due to chance (the chance model). Given the evidence provided, 
the stages model also seems unlikely. The finding that there are genes which appear to differentiate 
between the disorders (e.g. EN2, reeln, 5-HTT, SLC6A4, AVPR1A in ASD and NRG1, Neuregulin, 
DTNBP1, dysbindin, DAOA, D-serine, DARPP-32, GRM3, RGS4 for SSD, see Wang, Jeffries, & 
Wang, 2015) suggests strongly that ASD is not a first stage of SSD. Similarly, although there are high 
transition rates in some groups (COS and Multiple Complex Developmental Disorder), most 
individuals with ASD do not develop SSD and not all of those with SSD experience autism traits. 
Counterintuitively, as different areas of the brain are implicated in each disorder (for example, lower 
putamen volumes and grey matter volume in the left anterior insular in ASD compared to SSD, and 
overgrowth versus undergrowth of cortical surface area in ASD compared to COS; Baribeau & 
Anagnostou, 2013; Cheung et al., 2010; Radeloff et al., 2014) in order for the disorder to ‘progress’ 
from the ASD stage to the SSD stage, as hypothesised by the stages model, certain neuroanatomical 
areas would have to spontaneously improve, making this model extremely unlikely. 
There is limited evidence for the independence model. Retrospective research has identified two 
subgroups within SSD populations; a larger group with relatively little behavioural impairment 
throughout childhood, and a smaller group which displays early behavioural abnormalities (Corcoran 
et al., 2003; Rossi, Pollice, Daneluzzo, Marinangeli, & Stratta, 2000). This latter group has been 
found to have early onset SSD, greater impairment, a more chronic course of illness, and to display 
more negative symptoms (Myin-Germeys & van Os, 2007; Rossi et al., 2000), and has been suggested 
as a potential subgroup with a stronger association with ASD (Konstantareas & Hewitt, 2001). 
Adding support to this suggestion is a study by Goldstein et al. (2002) who classified participants with 
SSD psychometrically, based on neurocognitive performance, and compared the resulting four SSD 
subgroups to that of the ASD group. The cognitive profile of ASD was similar to only one SSD group 
which was characterised by deficits in complex information processing, but intact language and 
spatial ability. The independence model however, would predict just three distinct profiles of disorder; 
‘pure’ ASD, ‘pure’ SSD, and a third disorder with symptoms of both ASD and SSD. As ASD and 
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SSD are both highly heterogeneous these kind of clear-cut profiles (as opposed to the multiple profiles 
predicted by the multiple overlapping aetiologies model) seem unlikely.  
There is also only very limited evidence for the multiformity model, which suggests that the two 
disorders are different expressions of the same underlying disorder. The high number of individuals 
with 22q11.2 deletion syndrome who develop ASD and SSD suggests that 22q11.2 deletion syndrome 
may be an example of such an underlying disorder, of which ASD and SSD are two different 
expressions. On the other hand, individuals with 22q11.2 deletion may develop either ASD or SSD, or 
both ASD and SSD, but they can also develop neither. This suggests that 22q11.2 deletion syndrome 
is a vulnerability marker, rather than the underlying disorder itself; only through interaction with other 
factors (genetic or environmental) will a disorder develop. 22q11.2 deletion syndrome may therefore 
fit better with the associated liabilities or the multiple overlapping aetiologies model. The 
multiformity model also fails to explain co-occurrence of ASD and SSD in individuals without 
specific genetic conditions such as 22q11.2 deletion syndrome. Different brain areas, different 
environmental risk factors, and different genes are implicated in ASD and SSD, as well as different 
phenomenology such as age of onset, which Padgett et al. (2010) suggest makes the multiformity 
model extremely unlikely (although see Wang et al. (2015) for an opposing argument). A debate is 
needed on how many differentiating factors are needed before the underlying risk is considered to 
lead to an increased chance of developing two possible disorders, rather than considered to lead to 
two different expressions of the same disorder.  
Evidence is stronger for the increased vulnerability, diametrical, associated liabilities, and multiple 
overlapping aetiologies models. Esterberg et al. (2008) found that although childhood ASD traits 
were not predictive of transition, they were predictive of UHR status, giving support for the increased 
vulnerability model’s hypothesis that one disorder may predispose the other. Similarly, longitudinal 
evidence that psychotic like experiences at age 12 are associated with ASD traits in childhood (Bevan 
Jones et al., 2012; Sullivan et al., 2013), children diagnosed with ASD are more likely to experience 
symptoms of psychosis later in life (Joshi et al., 2013; Sullivan et al., 2013), those who develop SSD 
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often first experience childhood deficits which mimic ASD traits (Dickson et al., 2011) and children 
diagnosed with ASD are more likely to develop psychosis later in life than their non-diagnosed 
siblings (Selton, 2015) lends further endorsement to the model. Further support comes from Toal et 
al.’s (2009) hypothesis that due to the anatomical similarities between individuals with ASD and 
individuals with SSD, relatively small additional abnormalities or insults to the brain may be required 
for individuals with ASD to transition to SSD. Taken together, these findings suggest that, at least for 
a subset of individuals, ASD may represent a pathway into SSD.   
Comparative studies lend strong support to the diametrical model suggesting that ASD and SSD are 
associated with opposing genetic relationships as well as opposing effects on observed behaviour and 
cognition. Central to this model is that ASD and SSD represent the extremes of a social cognition 
continuum (Abu-Akel & Bailey, 2000; Crespi & Badcock, 2008), wherein ASD is associated with 
underdeveloped social cognition and SSD (at least in the paranoid type) with a high level of 
dysfunctional hyper-mentalising, deviating in opposite directions from normality. Recent comparative 
genomic studies demonstrate that both disorders are associated with genetic risk factors in a 
pleiotropic manner (Crespi et al., 2010), such that deletion of CNVs predispose the individual to 
developing one disorder and duplication predisposing the other. Also commensurate with this model 
are studies showing that ASD and SSD are diametrically opposed in local versus global processing 
(Russell-Smith et al., 2010), convergent versus divergent thinking (Nettle, 2006), as well as in under- 
versus over-mentalising (for a review see Frith, 2004). Toal et al’s (2009) hypothesis that their 
comorbid ASD and SSD population had anatomical changes which were more similar to UHR 
populations than SSD populations also gives some support to the diametrical model, which would 
argue that individuals who experience both SSD and ASD will benefit from the diametrical nature of 
the disorders. That is, the ASD will cause a deficit in one direction and the SSD in the opposite 
direction, meaning that those with both SSD and ASD will experience fewer deficits than those with 
just one of the disorders, although this remains to be more thoroughly investigated. 
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It seems evident that the disorders do share a high number of shared genetic and environmental risk 
factors as suggested by the associated liabilities model. Evidence from neuroimaging also lends 
support to this model, although to date, clear evidence is somewhat lacking as to whether the 
differences seen are neurodevelopmental (present before symptom onset) or neuroprogressive (only 
develop later: see Olabi et al., 2011 for a meta-analysis of progressive brain changes in SSD). There is 
also strong evidence for the multiple overlapping aetiologies model. While similar in some ways to 
the independence model, the multiple overlapping aetiologies model takes into account the highly 
heterogeneous nature of both disorders. This allows for two distinct disorder profiles to exist, albeit 
with considerable overlap in some areas. An example of this can be seen in Goldstein et al.’s (2002) 
four neurocognitive performance profiles of individuals with SSD, only one of which had a similar 
cognitive profile to those with ASD. Within ASD research the hypothesis that there may be many 
causal pathways is well acknowledged, with many authors proposing that the idea of ‘the autisms’ 
may be a more constructive way to conceptualise ASD than a concept of one unified disorder 
(Geschwind & Levitt, 2007; Whitehouse & Stanley, 2013). The idea of ‘the schizophrenias’ may also 
be a useful construct, with a recent genome-wide association study suggesting that there may be 
several ‘schizophrenias’ with genetically distinct causes. Arnedo et al. (2015) found 42 interacting 
single-nucleotide polymorphism (SNPs) clusters which resulted in several distinct clinical syndromes, 
all of which met diagnostic criteria for schizophrenia. Cicchetti and Rogosch (1996) discuss 
multifinality, where the same genotypic network can result in varying clinical outcomes, and 
equifinality, where different genotypic networks lead to the same clinical outcome. Both multifinality 
and equifinality are found within complex disorders. It is possible that both may be occurring within 
ASD and SSD. 
6.1 The possibility of subgroups  
It is important to note that these models of association are not mutually exclusive. Neither SSD nor 
ASD are known for their homogenous populations. The multiple overlapping aetiologies model 
hypothesises that subgroups exist within each disorder with diverse developmental pathways, and it is 
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entirely possible that that different models may apply to different subgroups. It seems likely, for 
example, that the high number of shared environmental and genetic risk factors does account for at 
least some of the co-occurrence of the disorders, making the associated liabilities model a strong 
candidate for explaining the co-occurrence. This doesn’t preclude the possibility however, that other 
models may also come into play. For example, certain profiles of disorders, including COS (Padgett et 
al., 2010), and Multiple Complex Developmental Disorder (Sprong et al., 2008), have been suggested 
to have a stronger association, suggesting that co-occurrence within these specific subgroups may be 
accounted for by an additional model, such as the increased vulnerability model. This means that the 
multiple overlapping aetiologies model, associated liabilities model, and increased vulnerability 
model may all co-exist and enhance the co-occurrence of the disorders. 
Caution is needed however, as even within these subgroups there are additional subgroups, with 
Rapoport et al. (2009) reporting that rare CNVs are found to a much greater extent in COS 
participants who have experienced developmental disturbances prior to onset. It is important that the 
disorders are not simply fractured into smaller and smaller categories as splintering the diagnoses into 
small and highly specific descriptions may reduce their usefulness. An alternative to this comes from 
a conceptual version of the multiple overlapping aetiologies model wherein Craddock & Owen (2010) 
hypothesise that the disorders exist on a continua of psychiatric syndromes, which range from a high 
neurodevelopmental contribution to the illness on one end, to a high degree of affective pathology on 
the other. Within this model, the clinical classifications of SSD and ASD are adjacent, but 
dimensionally there is substantial overlap between them, reflecting the shared traits, genetic 
contributions and other risk factors. This compliments the suggestion that some subgroups may have a 
stronger neurodevelopmental component (Jones et al., 1994; Jones, Rantakallio, Hartikainen, 
Isohanni, & Sipila, 1998). 
7. Suggestions for future research  
Presently no one model can currently be seen as being the ‘best fit’ for explaining the co-occurrence 
of ASD and SSD, and further research is therefore needed to establish this. It is important that future 
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research takes into account the strong evidence for the existence of different subgroups within both 
disorders. Additionally, subgroups should ideally be defined by multivariate data, rather than pre-
specified. Hypotheses need to be investigated for each subgroup individually, as not all models will 
necessarily apply to all subgroups and heterogeneity may confound true associations. When 
investigating subgroups it is important to ideally consider evidence on multiple levels, phenotypic as 
well as genotypic (Arnedo et al., 2015), or to psychometrically identify endophenotypic markers 
(Goldstein et al., 2002). Similarly, it is important that the dimensional nature of both disorders is 
taken into account when investigating the association between them. Of the 8 models discussed there 
is most evidence for the diametrical model, the associated liabilities model, the multiple overlapping 
aetiologies model, and the increased vulnerability model. Suggestions for future research 
investigating these models are provided below. 
7.1 The diametrical model 
The primary prediction of the diametrical model is that the two disorders are diametrically opposed. 
This means that in clinical populations those with co-occurring ASD and SSD, instead of 
experiencing higher levels of deficit (where the combination of having both disorders creates an 
additive affect), will experience lower levels of deficit as the diametrical nature of the disorders will 
ameliorate any difficulties. For example, in the general population, individuals with high traits of 
ASD and SSD (high/high individuals) do better on social and/or cognitive measures compared to 
those who have a high level of traits in only one of the disorders (high/low or low/high individuals; 
Abu-Akel, Wood. Hansen & Apperly, 2014). Research is needed which directly compares individuals 
with co-morbid ASD and SSD with those who only meet diagnostic criteria for one of the disorders in 
terms of their phenotypic expression, brain structure and functioning, and genetic architecture. Much 
of the evidence for the diametrical model comes from comparing individuals with ASD and 
individuals with paranoid type SSD. Further research is needed to see if the diametrical model may 
apply to other SSD subtypes. 
7.2 The associated liabilities model 
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There are many examples of shared underlying risk or liability between the disorders. The associated 
liabilities model however, is in many ways the polar opposite of the diametric model. It may be that 
the two models are both correct, but for different sub-populations. Research into populations which 
provide some evidence for the associated liabilities model, such as those with 22q11.2 deletion 
syndrome, will enable a closer evaluation of this model. Phenotypic behaviours in individuals with 
22q11.2 deletion syndrome who develop both ASD and SSD (high/high individuals) can help to shed 
some light on which of these models may be correct. If those with co-morbid ASD and SSD 
experience the same or additional deficit compared to those with only one disorder then the associated 
liabilities model is supported. Conversely, if deficit is ameliorated in high/high individuals then the 
diametrical model gains support.  
7.3 The multiple overlapping aetiologies model  
The multiple overlapping aetiologies model predicts that there are lots of different subtypes of SSD 
and ASD, some of which will share aetiologies. Some of these pathways may be diametrically 
opposed and others due to associated liability or increased vulnerability, so the multiple overlapping 
aetiologies model is not necessarily at odds with the other models of co-occurrence. Research has 
begun to characterise the phenotypic and genotypic architecture of SSD (e.g. Arnedo et al., 2015), 
finding multiple ‘schizophrenias’. The next step for investigating the co-occurrence of ASD and SSD 
should be to characterise the phenotypic and genotypic architecture of these disorders together, 
evaluating endophenotypic markers for both disorders. If characterised in this way, the multiple 
overlapping aetiologies model predicts that some of these disorders will share multiple pathways or 
markers, whilst others will remain distinct. 
7.4 The increased vulnerability model   
Although clearly not the case in all SSD populations, evidence is suggestive that ASD may represent a 
pathway into SSD for certain subgroups, including those with COS, Multiple Complex 
Developmental Disorder, and deficit schizophrenia populations. In contrast to the associated 
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liabilities model, the increased vulnerability model hypothesises that it is not the shared liability 
which makes individuals vulnerable to developing both ASD and SSD, but the actual development of 
ASD itself (or high trait level of ASD) which increases vulnerability for SSD. If this is the case it 
would be expected that in individuals with known underlying liabilities, SSD should be more common 
in those who first develop ASD than those who do not. One way to investigate this could be to utilise 
the finding that the offspring of parents with SSD are at an increased risk of ASD (Larsson et al., 
2005; Sullivan et al., 2012). The increased vulnerability model would predict that the offspring of 
parents with SSD who are diagnosed with ASD are at a much higher risk of developing a SSD when 
older than offspring who are typically developing in childhood. This type of research could be 
feasible with large population cohorts such as the Swedish or Danish population registers. In addition, 
the increased vulnerability model would predict that those who have ASD and go on to develop SSD 
would experience either the same or additional deficits compared to those with only ASD or SSD, 
rather than experiencing an ameliorating effect of developing the additional disorder (as predicted by 
the diametrical disorder). 
7.5 Limitations of proposed studies 
Whilst the proposed studies would provide an excellent starting point to begin investigating potential 
models underlying the co-occurrence of ASD and SSD, it is important that their limitations are also 
recognised. Particularly salient is the possibility of models co-existing with each other. If this is the 
case (and it seems entirely likely that it is) then research such as that proposed above may not be able 
to definitively identify one particular model whilst ruling out all other models. It is important that 
future research account for this possibility and, if a particular model seems likely, that investigators 
attempts to define exactly what the model applies to, be it a particular subgroup of individuals (as may 
be the case with the increased vulnerability model) or to certain types of symptoms (as is possible 
with the diametric model). It is also important that research differentiate between traits of ASD, which 
should remain stable, and early or prodromal signs of SSD, which are unlikely to be stable (i.e. may 
develop after 2 years of age and may worsen over time, or go into remission). 
27 
 
A further complication comes from the co-occurrence of both ASD and SSD with other disorders. Bi-
polar disorder for example, for which there is evidence of an overlap with SSD (Möller, 2003), also 
co-occurs above chance level with ASD, with rates ranging from 6% to 21.4% (Vannucchi, 2014). If 
considering the co-occurrence of multiple disorders, rather than just two disorders, the complexity of 
the issue multiplies significantly. 
8. Conclusions 
It is becoming increasingly evident that it is necessary to prospectively investigate the co-occurrence 
of, and commonalities between SSD and ASD at the trait level using multi-factorial data from large 
samples. Undiagnosed co-occurring disorders may result in individuals not receiving appropriate 
services, benefits, or treatment, and given the similarities between disorders, misdiagnosis is possible 
(Davidson et al., 2014; Wing, 1981a). It is important that future research account for the heterogeneity 
of both disorders, and examine evidence on multiple levels to identify endophenotypic markers, as 
well as taking the dimensional nature of the disorders into consideration. Together, these approaches 
can provide an important conceptual framework for understanding the association between ASD and 
SSD. This in turn may lead towards the development of a fundamental understanding of the two 
disorders. 
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